Zwitterionic Photosensitizer-Assembled Nanocluster Produces Efficient Photogenerated Radicals via Autoionization for Superior Antibacterial Photodynamic Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39924790.
- Also identified by DOI 10.1002/adma.202418978.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Photodynamic therapy (PDT) holds significant promise for antibacterial treatment, with its potential markedly amplified when using Type I photosensitizers (PSs). However, developing Type I PSs remains a significant challenge due to a lack of reliable design strategy. Herein, a Type I PS nanocluster is developed via self-assembly of zwitterionic small molecule (C3TH) for superior antibacterial PDT in vivo. Mechanism studies demonstrate that unique cross-arranged C3TH within nanocluster not only shortens intermolecular distance but also inhibits intermolecular electronic-vibrational coupling, thus facilitating intermolecular photoinduced electron transfer to form PS radical cation and anion via autoionization reaction. Subsequently, these highly oxidizing or reducing PS radicals engage in cascade photoredox to generate efficient ·OH and O<sub>2</sub>‾·. As a result, C3TH nanoclusters achieve a 97.6% antibacterial efficacy against MRSA at an ultralow dose, surpassing the efficacy of the commercial antibiotic Vancomycin by more than 8.8-fold. These findings deepen the understanding of Type I PDT, providing a novel strategy for developing Type I PSs.
Medical subject headings
- Photosensitizing Agents
- Anti-Bacterial Agents
- Photochemotherapy